| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.073 | 0.2 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.068 | 0.2 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |